2021 Q1 Form 10-Q Financial Statement
#000127547721000002 Filed on May 14, 2021
Income Statement
Concept | 2021 Q1 | 2020 Q4 | 2020 Q1 |
---|---|---|---|
Revenue | $3.142M | $3.353M | $4.129M |
YoY Change | -23.91% | -28.2% | -0.8% |
Cost Of Revenue | $289.4K | $300.5K | $1.277M |
YoY Change | -77.34% | -77.31% | -25.71% |
Gross Profit | $3.511M | $3.053M | -$13.23M |
YoY Change | -126.55% | -8.75% | -447.84% |
Gross Profit Margin | 111.74% | 91.04% | -320.27% |
Selling, General & Admin | $1.757M | $1.660M | $1.706M |
YoY Change | 2.97% | 2.84% | 5.24% |
% of Gross Profit | 50.03% | 54.38% | |
Research & Development | |||
YoY Change | |||
% of Gross Profit | |||
Depreciation & Amortization | $17.31K | $17.32K | $17.60K |
YoY Change | -1.62% | -4.68% | -4.62% |
% of Gross Profit | 0.49% | 0.57% | |
Operating Expenses | $1.756M | $1.660M | $1.706M |
YoY Change | 2.93% | 2.84% | 5.24% |
Operating Profit | $1.755M | $1.393M | -$14.93M |
YoY Change | -111.75% | -19.56% | -784.57% |
Interest Expense | |||
YoY Change | |||
% of Operating Profit | |||
Other Income/Expense, Net | $658.4K | -$16.08M | |
YoY Change | -104.1% | -1283.04% | |
Pretax Income | $1.755M | $1.393M | -$14.93M |
YoY Change | -111.75% | -19.56% | -784.57% |
Income Tax | $500.0K | -$10.67M | $7.400M |
% Of Pretax Income | 28.49% | -765.84% | |
Net Earnings | $1.290M | $12.06M | -$22.33M |
YoY Change | -105.78% | -6.93% | -1479.77% |
Net Earnings / Revenue | 41.07% | 359.59% | -540.83% |
Basic Earnings Per Share | |||
Diluted Earnings Per Share | $110.9K | $1.036M | -$1.919M |
COMMON SHARES | |||
Basic Shares Outstanding | |||
Diluted Shares Outstanding |
Balance Sheet
Concept | 2021 Q1 | 2020 Q4 | 2020 Q1 |
---|---|---|---|
SHORT-TERM ASSETS | |||
Cash & Short-Term Investments | $5.973M | $7.558M | $5.871M |
YoY Change | 1.74% | -6.34% | 17.34% |
Cash & Equivalents | $5.973M | $7.558M | $5.871M |
Short-Term Investments | |||
Other Short-Term Assets | |||
YoY Change | |||
Inventory | |||
Prepaid Expenses | |||
Receivables | $212.1K | $202.2K | $223.3K |
Other Receivables | $711.7K | $632.5K | $0.00 |
Total Short-Term Assets | $6.897M | $8.393M | $6.094M |
YoY Change | 13.17% | -4.85% | 5.66% |
LONG-TERM ASSETS | |||
Property, Plant & Equipment | $2.076M | $2.093M | $2.145M |
YoY Change | -3.23% | -3.24% | -34.58% |
Goodwill | |||
YoY Change | |||
Intangibles | |||
YoY Change | |||
Long-Term Investments | $72.86M | $65.18M | $54.44M |
YoY Change | 33.82% | -70.08% | -74.28% |
Other Assets | $38.24M | $38.02M | $27.20M |
YoY Change | 40.59% | -0.08% | 12.27% |
Total Long-Term Assets | $130.3M | $120.3M | $92.02M |
YoY Change | 41.64% | -55.55% | -63.63% |
TOTAL ASSETS | |||
Total Short-Term Assets | $6.897M | $8.393M | $6.094M |
Total Long-Term Assets | $130.3M | $120.3M | $92.02M |
Total Assets | $137.2M | $128.7M | $98.11M |
YoY Change | 39.88% | -53.95% | -62.09% |
SHORT-TERM LIABILITIES | |||
YoY Change | |||
Accounts Payable | |||
YoY Change | |||
Accrued Expenses | $91.84K | $107.4K | $109.6K |
YoY Change | -16.18% | -83.35% | -74.8% |
Deferred Revenue | |||
YoY Change | |||
Short-Term Debt | $73.14M | $65.07M | $52.36M |
YoY Change | 39.69% | -69.01% | -73.71% |
Long-Term Debt Due | |||
YoY Change | |||
Total Short-Term Liabilities | $73.23M | $65.18M | $52.47M |
YoY Change | 39.57% | -69.05% | -73.71% |
LONG-TERM LIABILITIES | |||
Long-Term Debt | $27.61M | $27.61M | $27.48M |
YoY Change | 0.48% | 0.48% | 2.51% |
Other Long-Term Liabilities | $619.6K | $1.421M | $523.9K |
YoY Change | 18.27% | -0.71% | -71.47% |
Total Long-Term Liabilities | $28.23M | $29.03M | $28.00M |
YoY Change | 0.81% | 0.42% | -2.24% |
TOTAL LIABILITIES | |||
Total Short-Term Liabilities | $73.23M | $65.18M | $52.47M |
Total Long-Term Liabilities | $28.23M | $29.03M | $28.00M |
Total Liabilities | $101.5M | $94.21M | $80.47M |
YoY Change | 26.08% | -60.66% | -64.74% |
SHAREHOLDERS EQUITY | |||
Retained Earnings | -$298.2M | -$315.0M | |
YoY Change | 1.88% | 3.5% | |
Common Stock | |||
YoY Change | |||
Preferred Stock | |||
YoY Change | |||
Treasury Stock (at cost) | |||
YoY Change | |||
Treasury Stock Shares | |||
Shareholders Equity | $35.78M | $34.49M | $17.60M |
YoY Change | |||
Total Liabilities & Shareholders Equity | $137.2M | $128.7M | $98.11M |
YoY Change | 39.88% | -53.95% | -62.09% |
Cashflow Statement
Concept | 2021 Q1 | 2020 Q4 | 2020 Q1 |
---|---|---|---|
OPERATING ACTIVITIES | |||
Net Income | $1.290M | $12.06M | -$22.33M |
YoY Change | -105.78% | -6.93% | -1479.77% |
Depreciation, Depletion And Amortization | $17.31K | $17.32K | $17.60K |
YoY Change | -1.62% | -4.68% | -4.62% |
Cash From Operating Activities | $109.9K | $1.145M | -$3.568M |
YoY Change | -103.08% | -43.52% | 160.26% |
INVESTING ACTIVITIES | |||
Capital Expenditures | $0.00 | ||
YoY Change | |||
Acquisitions | |||
YoY Change | |||
Other Investing Activities | -$9.070M | $8.296M | $155.5M |
YoY Change | -105.83% | -115.17% | 4807.87% |
Cash From Investing Activities | -$9.070M | $8.296M | $155.5M |
YoY Change | -105.83% | -115.17% | 4807.87% |
FINANCING ACTIVITIES | |||
Cash Dividend Paid | |||
YoY Change | |||
Common Stock Issuance & Retirement, Net | $0.00 | $0.00 | |
YoY Change | -100.0% | ||
Debt Paid & Issued, Net | $5.420K | $5.077K | |
YoY Change | 6.76% | ||
Cash From Financing Activities | $8.059M | -5.619M | -$157.6M |
YoY Change | -105.11% | -110.01% | 12492.62% |
NET CHANGE | |||
Cash From Operating Activities | $109.9K | 1.145M | -$3.568M |
Cash From Investing Activities | -$9.070M | 8.296M | $155.5M |
Cash From Financing Activities | $8.059M | -5.619M | -$157.6M |
Net Change In Cash | -$900.5K | 3.821M | -$5.650M |
YoY Change | -84.06% | 9.36% | -1134.47% |
FREE CASH FLOW | |||
Cash From Operating Activities | $109.9K | $1.145M | -$3.568M |
Capital Expenditures | $0.00 | ||
Free Cash Flow | $109.9K | ||
YoY Change |
Facts In Submission
Frame | Concept Type | Concept / XBRL Key | Value | Unit |
---|---|---|---|---|
CY2021Q1 | us-gaap |
Investment Income Interest
InvestmentIncomeInterest
|
610618 | USD |
CY2021Q1 | us-gaap |
Common Stock Value Outstanding
CommonStockValueOutstanding
|
11673 | USD |
CY2020Q4 | us-gaap |
Common Stock Value Outstanding
CommonStockValueOutstanding
|
11673 | USD |
CY2021Q1 | dei |
Amendment Flag
AmendmentFlag
|
false | |
CY2021Q1 | dei |
Document Fiscal Year Focus
DocumentFiscalYearFocus
|
2021 | |
CY2021Q1 | dei |
Document Fiscal Period Focus
DocumentFiscalPeriodFocus
|
Q1 | |
CY2021Q1 | dei |
Entity Central Index Key
EntityCentralIndexKey
|
0001275477 | |
CY2021Q1 | dei |
Current Fiscal Year End Date
CurrentFiscalYearEndDate
|
--12-31 | |
CY2021Q1 | dei |
Document Type
DocumentType
|
10-Q | |
CY2021Q1 | dei |
Document Quarterly Report
DocumentQuarterlyReport
|
true | |
CY2021Q1 | dei |
Document Period End Date
DocumentPeriodEndDate
|
2021-03-31 | |
CY2021Q1 | dei |
Document Transition Report
DocumentTransitionReport
|
false | |
CY2021Q1 | dei |
Entity File Number
EntityFileNumber
|
001-32171 | |
CY2021Q1 | dei |
Entity Registrant Name
EntityRegistrantName
|
Bimini Capital Management, Inc. | |
CY2021Q1 | dei |
Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
|
MD | |
CY2021Q1 | dei |
Entity Tax Identification Number
EntityTaxIdentificationNumber
|
72-1571637 | |
CY2021Q1 | dei |
Entity Address Address Line1
EntityAddressAddressLine1
|
3305 Flamingo Drive | |
CY2021Q1 | dei |
Entity Address City Or Town
EntityAddressCityOrTown
|
Vero Beach | |
CY2021Q1 | dei |
Entity Address State Or Province
EntityAddressStateOrProvince
|
FL | |
CY2021Q1 | dei |
Entity Address Postal Zip Code
EntityAddressPostalZipCode
|
32963 | |
CY2021Q1 | dei |
City Area Code
CityAreaCode
|
772 | |
CY2021Q1 | dei |
Local Phone Number
LocalPhoneNumber
|
231-1400 | |
CY2021Q1 | dei |
Entity Current Reporting Status
EntityCurrentReportingStatus
|
Yes | |
CY2021Q1 | dei |
Entity Interactive Data Current
EntityInteractiveDataCurrent
|
Yes | |
CY2021Q1 | dei |
Entity Filer Category
EntityFilerCategory
|
Non-accelerated Filer | |
CY2021Q1 | dei |
Entity Small Business
EntitySmallBusiness
|
true | |
CY2021Q1 | dei |
Entity Emerging Growth Company
EntityEmergingGrowthCompany
|
false | |
CY2021Q1 | dei |
Entity Shell Company
EntityShellCompany
|
false | |
CY2021Q1 | us-gaap |
Financial Instruments Owned And Pledged As Collateral At Fair Value
FinancialInstrumentsOwnedAndPledgedAsCollateralAtFairValue
|
72833006 | USD |
CY2020Q4 | us-gaap |
Financial Instruments Owned And Pledged As Collateral At Fair Value
FinancialInstrumentsOwnedAndPledgedAsCollateralAtFairValue
|
65153274 | USD |
CY2021Q1 | us-gaap |
Financial Instruments Owned And Not Pledged At Fair Value
FinancialInstrumentsOwnedAndNotPledgedAtFairValue
|
22826 | USD |
CY2020Q4 | us-gaap |
Financial Instruments Owned And Not Pledged At Fair Value
FinancialInstrumentsOwnedAndNotPledgedAtFairValue
|
24957 | USD |
CY2021Q1 | us-gaap |
Financial Instruments Owned Us Government And Agency Obligations At Fair Value
FinancialInstrumentsOwnedUSGovernmentAndAgencyObligationsAtFairValue
|
72855832 | USD |
CY2021Q1 | us-gaap |
Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
|
4037655 | USD |
CY2021Q1 | us-gaap |
Financial Instruments Owned Corporate Equities At Fair Value
FinancialInstrumentsOwnedCorporateEquitiesAtFairValue
|
15598096 | USD |
CY2020Q4 | us-gaap |
Financial Instruments Owned Corporate Equities At Fair Value
FinancialInstrumentsOwnedCorporateEquitiesAtFairValue
|
13547764 | USD |
CY2020Q4 | us-gaap |
Interest Receivable
InterestReceivable
|
202192 | USD |
CY2021Q1 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
2076127 | USD |
CY2020Q4 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
2093440 | USD |
CY2021Q1 | us-gaap |
Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
|
34204364 | USD |
CY2020Q4 | us-gaap |
Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
|
34668467 | USD |
CY2021Q1 | us-gaap |
Due From Affiliate Current
DueFromAffiliateCurrent
|
711657 | USD |
CY2020Q4 | us-gaap |
Due From Affiliate Current
DueFromAffiliateCurrent
|
632471 | USD |
CY2021Q1 | us-gaap |
Prepaid Expense And Other Assets
PrepaidExpenseAndOtherAssets
|
1564005 | USD |
CY2020Q4 | us-gaap |
Prepaid Expense And Other Assets
PrepaidExpenseAndOtherAssets
|
1466647 | USD |
CY2021Q1 | us-gaap |
Assets
Assets
|
137233034 | USD |
CY2020Q4 | us-gaap |
Other Liabilities
OtherLiabilities
|
1421409 | USD |
CY2020Q4 | us-gaap |
Interest Payable Current And Noncurrent
InterestPayableCurrentAndNoncurrent
|
107417 | USD |
CY2021Q1 | us-gaap |
Revenues
Revenues
|
3142122 | USD |
CY2021Q1 | us-gaap |
Securities Sold Under Agreements To Repurchase
SecuritiesSoldUnderAgreementsToRepurchase
|
73135999 | USD |
CY2020Q4 | us-gaap |
Securities Sold Under Agreements To Repurchase
SecuritiesSoldUnderAgreementsToRepurchase
|
65071113 | USD |
CY2021Q1 | us-gaap |
Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
|
27607361 | USD |
CY2020Q4 | us-gaap |
Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
|
27612781 | USD |
CY2021Q1 | us-gaap |
Interest Payable Current And Noncurrent
InterestPayableCurrentAndNoncurrent
|
91841 | USD |
CY2021Q1 | us-gaap |
Liabilities
Liabilities
|
101454755 | USD |
CY2021Q1 | us-gaap |
Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
|
10000000 | shares |
CY2020Q4 | us-gaap |
Preferred Stock Value
PreferredStockValue
|
0 | USD |
CY2020Q4 | us-gaap |
Additional Paid In Capital
AdditionalPaidInCapital
|
332642758 | USD |
CY2020Q4 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-298166582 | USD |
CY2021Q1 | us-gaap |
Stockholders Equity
StockholdersEquity
|
35778279 | USD |
CY2021Q1 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
137233034 | USD |
CY2021Q1 | us-gaap |
Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
|
2025409 | USD |
CY2020Q1 | us-gaap |
Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
|
1724597 | USD |
CY2020Q1 | us-gaap |
Investment Income Interest
InvestmentIncomeInterest
|
2039994 | USD |
CY2021Q1 | us-gaap |
Investment Income Dividend
InvestmentIncomeDividend
|
506095 | USD |
CY2020Q1 | us-gaap |
Investment Income Dividend
InvestmentIncomeDividend
|
364809 | USD |
CY2020Q1 | us-gaap |
Revenues
Revenues
|
4129400 | USD |
CY2020Q1 | us-gaap |
Repurchase Agreements Interest Expense Amount
RepurchaseAgreementsInterestExpenseAmount
|
927816 | USD |
CY2020Q1 | us-gaap |
Interest Expense Long Term Debt
InterestExpenseLongTermDebt
|
349501 | USD |
CY2021Q1 | us-gaap |
Revenues Net Of Interest Expense
RevenuesNetOfInterestExpense
|
2852716 | USD |
CY2020Q1 | us-gaap |
Revenues Net Of Interest Expense
RevenuesNetOfInterestExpense
|
2852083 | USD |
CY2020Q1 | us-gaap |
Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
|
-574281 | USD |
CY2020Q1 | us-gaap |
Marketable Securities Realized Gain Loss
MarketableSecuritiesRealizedGainLoss
|
-5804656 | USD |
CY2021Q1 | us-gaap |
Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
|
2050332 | USD |
CY2020Q1 | us-gaap |
Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
|
-4408105 | USD |
CY2021Q1 | us-gaap |
Gain Loss On Derivative Instruments Held For Trading Purposes Net
GainLossOnDerivativeInstrumentsHeldForTradingPurposesNet
|
243 | USD |
CY2020Q1 | us-gaap |
Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
|
324 | USD |
CY2020Q1 | us-gaap |
Nonoperating Income Expense
NonoperatingIncomeExpense
|
-16077449 | USD |
CY2020Q1 | us-gaap |
Labor And Related Expense
LaborAndRelatedExpense
|
1100044 | USD |
CY2020Q1 | us-gaap |
Noninterest Expense Directors Fees
NoninterestExpenseDirectorsFees
|
164581 | USD |
CY2020Q1 | us-gaap |
Professional Fees
ProfessionalFees
|
159293 | USD |
CY2020Q1 | us-gaap |
Other General And Administrative Expense
OtherGeneralAndAdministrativeExpense
|
282039 | USD |
CY2020Q1 | us-gaap |
Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
|
1705957 | USD |
CY2021Q1 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
|
1754533 | USD |
CY2020Q1 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
|
-14931323 | USD |
CY2021Q1 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
464103 | USD |
CY2020Q1 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
7401624 | USD |
CY2021Q1 | us-gaap |
Profit Loss
ProfitLoss
|
1290430 | USD |
CY2020Q1 | us-gaap |
Profit Loss
ProfitLoss
|
-22332947 | USD |
CY2020Q1 | us-gaap |
Profit Loss
ProfitLoss
|
-22332947 | USD |
CY2021Q1 | us-gaap |
Repurchase Agreements Interest Expense Amount
RepurchaseAgreementsInterestExpenseAmount
|
39858 | USD |
CY2021Q1 | us-gaap |
Interest Expense Long Term Debt
InterestExpenseLongTermDebt
|
249548 | USD |
CY2020Q1 | us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
155519616 | USD |
CY2020Q1 | bmnm |
Proceeds From Securities Sold Under Agreements To Repurchase
ProceedsFromSecuritiesSoldUnderAgreementsToRepurchase
|
361393397 | USD |
CY2020Q1 | us-gaap |
Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
17644044 | USD |
CY2020Q4 | us-gaap |
Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
34487849 | USD |
CY2021Q1 | us-gaap |
Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
35778279 | USD |
CY2021Q1 | bmnm |
Payments For Securities Sold Under Agreements To Repurchase
PaymentsForSecuritiesSoldUnderAgreementsToRepurchase
|
66734114 | USD |
CY2020Q1 | bmnm |
Payments For Securities Sold Under Agreements To Repurchase
PaymentsForSecuritiesSoldUnderAgreementsToRepurchase
|
518990000 | USD |
CY2021Q1 | us-gaap |
Repayments Of Debt
RepaymentsOfDebt
|
5420 | USD |
CY2020Q1 | us-gaap |
Repayments Of Debt
RepaymentsOfDebt
|
5077 | USD |
CY2021Q1 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
8059466 | USD |
CY2020Q1 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
-157601680 | USD |
CY2021Q1 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
|
-900455 | USD |
CY2020Q1 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
|
-5650359 | USD |
CY2020Q1 | us-gaap |
Unrealized Gain Loss On Derivatives And Commodity Contracts
UnrealizedGainLossOnDerivativesAndCommodityContracts
|
-1441406 | USD |
CY2021Q1 | us-gaap |
Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
|
9859 | USD |
CY2020Q1 | us-gaap |
Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
|
-527542 | USD |
CY2021Q1 | us-gaap |
Increase Decrease Due From Affiliates
IncreaseDecreaseDueFromAffiliates
|
79186 | USD |
CY2020Q1 | us-gaap |
Increase Decrease Due From Affiliates
IncreaseDecreaseDueFromAffiliates
|
-101800 | USD |
CY2021Q1 | us-gaap |
Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
|
97358 | USD |
CY2021Q1 | us-gaap |
Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
|
-15576 | USD |
CY2020Q1 | us-gaap |
Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
|
-535734 | USD |
CY2021Q1 | us-gaap |
Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
|
-801855 | USD |
CY2020Q1 | us-gaap |
Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
|
-849083 | USD |
CY2021Q1 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
109941 | USD |
CY2020Q1 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-3568295 | USD |
CY2021Q1 | bmnm |
Payments To Acquire Mortgage Backed Securities Mbs Categorized As Trading
PaymentsToAcquireMortgageBackedSecuritiesMbsCategorizedAsTrading
|
12367589 | USD |
CY2020Q1 | bmnm |
Payments To Acquire Mortgage Backed Securities Mbs Categorized As Trading
PaymentsToAcquireMortgageBackedSecuritiesMbsCategorizedAsTrading
|
20823373 | USD |
CY2021Q1 | bmnm |
Proceeds From Sale Of Mortgage Backed Securities Mbs Categorized As Trading
ProceedsFromSaleOfMortgageBackedSecuritiesMbsCategorizedAsTrading
|
0 | USD |
CY2021Q1 | us-gaap |
Profit Loss
ProfitLoss
|
1290430 | USD |
CY2020Q1 | us-gaap |
Profit Loss
ProfitLoss
|
-22332947 | USD |
CY2021Q1 | us-gaap |
Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
|
17313 | USD |
CY2020Q1 | us-gaap |
Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
|
17598 | USD |
CY2021Q1 | us-gaap |
Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
|
464103 | USD |
CY2020Q1 | bmnm |
Proceeds From Sale Of Mortgage Backed Securities Mbs Categorized As Trading
ProceedsFromSaleOfMortgageBackedSecuritiesMbsCategorizedAsTrading
|
171155249 | USD |
CY2021Q1 | bmnm |
Proceeds From Maturities Prepayments And Calls Of Mortgage Backed Securities Categorized As Trading
ProceedsFromMaturitiesPrepaymentsAndCallsOfMortgageBackedSecuritiesCategorizedAsTrading
|
3297727 | USD |
CY2021Q1 | us-gaap |
Payments For Proceeds From Derivative Instrument Investing Activities
PaymentsForProceedsFromDerivativeInstrumentInvestingActivities
|
0 | USD |
CY2020Q1 | us-gaap |
Payments For Proceeds From Derivative Instrument Investing Activities
PaymentsForProceedsFromDerivativeInstrumentInvestingActivities
|
1500000 | USD |
CY2021Q1 | us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
-9069862 | USD |
CY2021Q1 | us-gaap |
Gain Loss On Investments Excluding Other Than Temporary Impairments
GainLossOnInvestmentsExcludingOtherThanTemporaryImpairments
|
-1392261 | USD |
CY2020Q1 | us-gaap |
Gain Loss On Investments Excluding Other Than Temporary Impairments
GainLossOnInvestmentsExcludingOtherThanTemporaryImpairments
|
-6378937 | USD |
CY2021Q1 | us-gaap |
Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
|
2050332 | USD |
CY2020Q1 | us-gaap |
Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
|
-4408105 | USD |
CY2021Q1 | us-gaap |
Unrealized Gain Loss On Derivatives And Commodity Contracts
UnrealizedGainLossOnDerivativesAndCommodityContracts
|
0 | USD |
CY2020Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
10911357 | USD |
CY2019Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
12385117 | USD |
CY2021Q1 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
10010902 | USD |
CY2020Q1 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
6734758 | USD |
CY2021Q1 | us-gaap |
Interest Paid Net
InterestPaidNet
|
304982 | USD |
CY2020Q1 | us-gaap |
Interest Paid Net
InterestPaidNet
|
1813051 | USD |
CY2021Q1 | us-gaap |
Income Taxes Paid Net
IncomeTaxesPaidNet
|
0 | USD |
CY2020Q1 | us-gaap |
Income Taxes Paid Net
IncomeTaxesPaidNet
|
13465 | USD |
CY2021Q1 | us-gaap |
Financial Instruments Owned Us Government And Agency Obligations At Fair Value
FinancialInstrumentsOwnedUSGovernmentAndAgencyObligationsAtFairValue
|
72856000 | USD |
CY2021Q1 | us-gaap |
Gain Loss On Derivative Instruments Held For Trading Purposes Net
GainLossOnDerivativeInstrumentsHeldForTradingPurposesNet
|
0 | USD |
CY2021Q1 | us-gaap |
Use Of Estimates
UseOfEstimates
|
<div id="TextBlockContainer13" style="position:relative;font-family:Arial;font-size:14.72px;font-stretch:condensed;color:#000000;line-height:normal;width:726px;height:153px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a2345" style="position:absolute;font-weight:bold;font-style:normal;left:4.475px;top:0px;">Use of Estimates </div><div id="a2347" style="position:absolute;font-weight:normal;font-style:normal;left:4.475px;top:19.4px;"> </div><div id="a2348" style="position:absolute;font-weight:normal;font-style:normal;left:28.475px;top:38.8px;">The preparation of financial statements in conformity with GAAP requires management<div style="display:inline-block;width:1.84px"> </div>to make estimates and assumptions that </div><div id="a2350" style="position:absolute;font-weight:normal;font-style:normal;left:4.475px;top:58.2px;">affect the reported amounts of assets and liabilities and disclosure of contingent assets and<div style="display:inline-block;width:1.77px"> </div>liabilities at the date of the consolidated </div><div id="a2352" style="position:absolute;font-weight:normal;font-style:normal;left:4.475px;top:77.5px;">financial statements and the reported amounts of revenues and expenses during<div style="display:inline-block;width:2px"> </div>the reporting period. Actual results could differ from </div><div id="a2354" style="position:absolute;font-weight:normal;font-style:normal;left:4.475px;top:96.9px;">those estimates.<div style="display:inline-block;width:6.49px"> </div>Significant estimates affecting the accompanying consolidated financial statements include<div style="display:inline-block;width:1.95px"> </div>determining the fair </div><div id="a2356" style="position:absolute;font-weight:normal;font-style:normal;left:4.475px;top:116.2px;">values of MBS, investment in Orchid common shares and derivatives, determining<div style="display:inline-block;width:1.87px"> </div>the amounts of asset valuation allowances, and the </div><div id="a2358" style="position:absolute;font-weight:normal;font-style:normal;left:4.475px;top:135.6px;">computation of the income tax provision or benefit and the deferred tax asset allowances<div style="display:inline-block;width:1.92px"> </div>recorded for each accounting period.</div></div> | |
CY2020Q1 | us-gaap |
Gain Loss On Derivative Instruments Held For Trading Purposes Net
GainLossOnDerivativeInstrumentsHeldForTradingPurposesNet
|
-5291000 | USD |
CY2021Q1 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
5973247 | USD |
CY2020Q4 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
7558342 | USD |
CY2021Q1 | us-gaap |
Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
|
4037655 | USD |
CY2020Q4 | us-gaap |
Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
|
3353015 | USD |
CY2021Q1 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
10010902 | USD |
CY2020Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
10911357 | USD |
CY2021Q1 | bmnm |
Advisory Services Other Segments
AdvisoryServicesOtherSegments
|
0 | USD |
CY2021Q1 | us-gaap |
Interest And Dividend Income Operating
InterestAndDividendIncomeOperating
|
1117000 | USD |
CY2021Q1 | us-gaap |
Interest And Debt Expense
InterestAndDebtExpense
|
290000 | USD |
CY2021Q1 | bmnm |
Net Segment Revenue
NetSegmentRevenue
|
2852000 | USD |
CY2021Q1 | us-gaap |
Other Income
OtherIncome
|
659000 | USD |
CY2021Q1 | bmnm |
Gross Amount Of Recognized Liabilties
GrossAmountOfRecognizedLiabilties
|
73136000 | USD |
CY2021Q1 | bmnm |
Gross Amount Of Liabilties Offset In The Balance Sheet
GrossAmountOfLiabiltiesOffsetInTheBalanceSheet
|
0 | USD |
CY2021Q1 | bmnm |
Net Amount Of Liabilities Presented In The Balance Sheet
NetAmountOfLiabilitiesPresentedInTheBalanceSheet
|
73136000 | USD |
CY2021Q1 | bmnm |
Gross Amount Of Financial Instruments Posted Not Offset In Balance Sheet
GrossAmountOfFinancialInstrumentsPostedNotOffsetInBalanceSheet
|
-69099000 | USD |
CY2021Q1 | bmnm |
Gross Amounts Of Cash Posted Not Offset In Balance Sheet
GrossAmountsOfCashPostedNotOffsetInBalanceSheet
|
-4037000 | USD |
CY2021Q1 | bmnm |
Net Amount Of Liabilities
NetAmountOfLiabilities
|
0 | USD |
CY2020Q4 | bmnm |
Gross Amount Of Recognized Liabilties
GrossAmountOfRecognizedLiabilties
|
65071000 | USD |
CY2020Q4 | bmnm |
Gross Amount Of Liabilties Offset In The Balance Sheet
GrossAmountOfLiabiltiesOffsetInTheBalanceSheet
|
0 | USD |
CY2020Q4 | bmnm |
Net Amount Of Liabilities Presented In The Balance Sheet
NetAmountOfLiabilitiesPresentedInTheBalanceSheet
|
65071000 | USD |
CY2020Q4 | bmnm |
Gross Amount Of Financial Instruments Posted Not Offset In Balance Sheet
GrossAmountOfFinancialInstrumentsPostedNotOffsetInBalanceSheet
|
-61719000 | USD |
CY2020Q4 | bmnm |
Gross Amounts Of Cash Posted Not Offset In Balance Sheet
GrossAmountsOfCashPostedNotOffsetInBalanceSheet
|
-3352000 | USD |
CY2020Q4 | bmnm |
Net Amount Of Liabilities
NetAmountOfLiabilities
|
0 | USD |
CY2021Q1 | us-gaap |
Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
|
27607000 | USD |
CY2020Q4 | us-gaap |
Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
|
27613000 | USD |
CY2021Q1 | bmnm |
Scheduled Principal Payments
ScheduledPrincipalPayments
|
27455000 | USD |
CY2021Q1 | us-gaap |
Financial Instruments Owned Us Government And Agency Obligations At Fair Value
FinancialInstrumentsOwnedUSGovernmentAndAgencyObligationsAtFairValue
|
72856000 | USD |
CY2021Q1 | us-gaap |
Financial Instruments Owned Corporate Equities At Fair Value
FinancialInstrumentsOwnedCorporateEquitiesAtFairValue
|
15598000 | USD |
CY2020Q4 | us-gaap |
Financial Instruments Owned Corporate Equities At Fair Value
FinancialInstrumentsOwnedCorporateEquitiesAtFairValue
|
13548000 | USD |
CY2021Q1 | us-gaap |
Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
|
2025000 | USD |
CY2021Q1 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
500000 | USD |
CY2020Q1 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
7400000 | USD |
CY2021Q1 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
|
1800000 | USD |
CY2020Q1 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
|
-14900000 | USD |
CY2020Q1 | us-gaap |
Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
|
11200000 | USD |
CY2019Q1 | us-gaap |
Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
|
1286000 | USD |
CY2021Q1 | us-gaap |
Operating Expenses
OperatingExpenses
|
1756000 | USD |
CY2021Q1 | bmnm |
Intercompany Expenses
IntercompanyExpenses
|
0 | USD |
CY2021Q1 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
|
1755000 | USD |
CY2020Q1 | us-gaap |
Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
|
1725000 | USD |
CY2020Q1 | bmnm |
Advisory Services Other Segments
AdvisoryServicesOtherSegments
|
0 | USD |
CY2020Q1 | us-gaap |
Interest And Dividend Income Operating
InterestAndDividendIncomeOperating
|
2405000 | USD |
CY2020Q1 | us-gaap |
Interest And Debt Expense
InterestAndDebtExpense
|
1278000 | USD |
CY2020Q1 | bmnm |
Net Segment Revenue
NetSegmentRevenue
|
2852000 | USD |
CY2020Q1 | us-gaap |
Other Income
OtherIncome
|
-16077000 | USD |
CY2020Q1 | us-gaap |
Operating Expenses
OperatingExpenses
|
1706000 | USD |
CY2020Q1 | bmnm |
Intercompany Expenses
IntercompanyExpenses
|
0 | USD |
CY2020Q1 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
|
-14931000 | USD |
CY2021Q1 | us-gaap |
Assets
Assets
|
137233000 | USD |
CY2020Q4 | us-gaap |
Assets
Assets
|
128701000 | USD |